位置:首页 > 蛋白库 > WBPB_PSEAE
WBPB_PSEAE
ID   WBPB_PSEAE              Reviewed;         316 AA.
AC   G3XD23; P72133; Q8KIQ7;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 1.
DT   03-AUG-2022, entry version 58.
DE   RecName: Full=UDP-N-acetyl-2-amino-2-deoxy-D-glucuronate oxidase;
DE            EC=1.1.1.335;
DE   AltName: Full=UDP-2-acetamido-2-deoxy-alpha-D-glucuronic acid 3-dehydrogenase;
DE   AltName: Full=UDP-N-acetyl-D-glucosaminuronic acid 3-oxidase;
DE            Short=UDP-D-GlcNAcA 3-oxidase {ECO:0000303|PubMed:18621892};
GN   Name=wbpB {ECO:0000312|EMBL:AAG06546.1}; Synonyms=wlbA;
GN   OrderedLocusNames=PA3158;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC45853.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PATHWAY.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1 {ECO:0000312|EMBL:AAC45853.1};
RX   PubMed=8939432; DOI=10.1046/j.1365-2958.1996.1351503.x;
RA   Burrows L.L., Charter D.F., Lam J.S.;
RT   "Molecular characterization of the Pseudomonas aeruginosa serotype O5
RT   (PAO1) B-band lipopolysaccharide gene cluster.";
RL   Mol. Microbiol. 22:481-495(1996).
RN   [2] {ECO:0000312|EMBL:AAM27797.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1 {ECO:0000269|PubMed:12057956};
RX   PubMed=12057956; DOI=10.1128/jb.184.13.3614-3622.2002;
RA   Raymond C.K., Sims E.H., Kas A., Spencer D.H., Kutyavin T.V., Ivey R.G.,
RA   Zhou Y., Kaul R., Clendenning J.B., Olson M.V.;
RT   "Genetic variation at the O-antigen biosynthetic locus in Pseudomonas
RT   aeruginosa.";
RL   J. Bacteriol. 184:3614-3622(2002).
RN   [3] {ECO:0000312|EMBL:AAG06546.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [4] {ECO:0000305}
RP   FUNCTION, AND PATHWAY.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1 {ECO:0000269|PubMed:18621892};
RX   PubMed=18621892; DOI=10.1128/jb.00579-08;
RA   Westman E.L., Preston A., Field R.A., Lam J.S.;
RT   "Biosynthesis of a rare di-N-acetylated sugar in the lipopolysaccharides of
RT   both Pseudomonas aeruginosa and Bordetella pertussis occurs via an
RT   identical scheme despite different gene clusters.";
RL   J. Bacteriol. 190:6060-6069(2008).
RN   [5] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND PATHWAY.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1 {ECO:0000269|PubMed:19348502};
RX   PubMed=19348502; DOI=10.1021/bi900186u;
RA   Larkin A., Imperiali B.;
RT   "Biosynthesis of UDP-GlcNAc(3NAc)A by WbpB, WbpE, and WbpD: enzymes in the
RT   Wbp pathway responsible for O-antigen assembly in Pseudomonas aeruginosa
RT   PAO1.";
RL   Biochemistry 48:5446-5455(2009).
RN   [6] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1 {ECO:0000269|PubMed:19282284};
RX   PubMed=19282284; DOI=10.1074/jbc.m808583200;
RA   Westman E.L., McNally D.J., Charchoglyan A., Brewer D., Field R.A.,
RA   Lam J.S.;
RT   "Characterization of WbpB, WbpE, and WbpD and reconstitution of a pathway
RT   for the biosynthesis of UDP-2,3-diacetamido-2,3-dideoxy-D-mannuronic acid
RT   in Pseudomonas aeruginosa.";
RL   J. Biol. Chem. 284:11854-11862(2009).
RN   [7] {ECO:0000305, ECO:0000312|PDB:3OA2}
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEX WITH NAD, FUNCTION,
RP   CATALYTIC ACTIVITY, KINETIC PARAMETERS, REACTION MECHANISM, AND SUBUNIT.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1 {ECO:0000269|PubMed:20690587};
RX   PubMed=20690587; DOI=10.1021/bi101103s;
RA   Thoden J.B., Holden H.M.;
RT   "Structural and functional studies of WlbA: a dehydrogenase involved in the
RT   biosynthesis of 2,3-diacetamido-2,3-dideoxy-D-mannuronic acid.";
RL   Biochemistry 49:7939-7948(2010).
CC   -!- FUNCTION: Plays a role in the biosynthesis of B-band O antigen for
CC       serotype O5. Catalyzes the NAD-dependent oxidation of UDP-N-
CC       acetylglucosaminuronic acid (UDP-D-GlcNAcA) to UDP-2-acetamido-2-deoxy-
CC       3-oxo-D-glucuronic acid (UDP-3-oxo-D-GlcNAcA). Cannot use UDP-GlcNAc or
CC       UDP-GalNAc as the nucleotide sugar substrate, and can use only poorly
CC       UDP-D-glucuronic acid (UDP-GlcA). Undergoes an NAD(+) recycling
CC       mechanism using 2-oxoglutarate as an oxidant.
CC       {ECO:0000269|PubMed:18621892, ECO:0000269|PubMed:19282284,
CC       ECO:0000269|PubMed:19348502, ECO:0000269|PubMed:20690587}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + UDP-N-2-acetamido-2-deoxy-alpha-D-glucuronate = H(+)
CC         + NADH + UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate;
CC         Xref=Rhea:RHEA:33579, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:62250, ChEBI:CHEBI:65040;
CC         EC=1.1.1.335; Evidence={ECO:0000269|PubMed:19282284,
CC         ECO:0000269|PubMed:19348502};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxyglutarate + NAD(+) = 2-oxoglutarate + H(+) + NADH;
CC         Xref=Rhea:RHEA:13449, ChEBI:CHEBI:11596, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16810, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.25 mM for UDP-GlcNAcA {ECO:0000269|PubMed:19348502,
CC         ECO:0000269|PubMed:20690587};
CC         KM=1.35 mM for 2-oxoglutarate {ECO:0000269|PubMed:19348502,
CC         ECO:0000269|PubMed:20690587};
CC         Vmax=28 umol/min/ug enzyme {ECO:0000269|PubMed:19348502,
CC         ECO:0000269|PubMed:20690587};
CC       pH dependence:
CC         Optimum pH is 8.0 for the coupled WbpB/WbpE reaction.
CC         {ECO:0000269|PubMed:19348502};
CC       Temperature dependence:
CC         Optimum temperature is 30 degrees Celsius for the coupled WbpB/WbpE
CC         reaction. {ECO:0000269|PubMed:19348502};
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; LPS O-antigen
CC       biosynthesis. {ECO:0000269|PubMed:18621892,
CC       ECO:0000269|PubMed:19282284, ECO:0000269|PubMed:19348502,
CC       ECO:0000269|PubMed:8939432}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:20690587}.
CC   -!- MISCELLANEOUS: Seems to proceed via a ping-pong reaction mechanism.
CC   -!- SIMILARITY: Belongs to the Gfo/Idh/MocA family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U50396; AAC45853.1; -; Genomic_DNA.
DR   EMBL; AF498416; AAM27797.1; -; Genomic_DNA.
DR   EMBL; AE004091; AAG06546.1; -; Genomic_DNA.
DR   PIR; H83251; H83251.
DR   RefSeq; NP_251848.1; NC_002516.2.
DR   RefSeq; WP_003113428.1; NZ_QZGE01000023.1.
DR   PDB; 3OA2; X-ray; 1.50 A; A/B/C/D=1-316.
DR   PDBsum; 3OA2; -.
DR   AlphaFoldDB; G3XD23; -.
DR   SMR; G3XD23; -.
DR   STRING; 208964.PA3158; -.
DR   PaxDb; G3XD23; -.
DR   DNASU; 882642; -.
DR   EnsemblBacteria; AAG06546; AAG06546; PA3158.
DR   GeneID; 882642; -.
DR   KEGG; pae:PA3158; -.
DR   PATRIC; fig|208964.12.peg.3302; -.
DR   PseudoCAP; PA3158; -.
DR   HOGENOM; CLU_862341_0_0_6; -.
DR   OMA; YIAPRHM; -.
DR   PhylomeDB; G3XD23; -.
DR   BioCyc; MetaCyc:MON-17573; -.
DR   BioCyc; PAER208964:G1FZ6-3218-MON; -.
DR   BRENDA; 1.1.1.335; 5087.
DR   UniPathway; UPA00281; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0070403; F:NAD+ binding; IDA:UniProtKB.
DR   GO; GO:0070404; F:NADH binding; IDA:UniProtKB.
DR   GO; GO:0003954; F:NADH dehydrogenase activity; EXP:PseudoCAP.
DR   GO; GO:0004617; F:phosphoglycerate dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0009243; P:O antigen biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0000271; P:polysaccharide biosynthetic process; IDA:PseudoCAP.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:0006065; P:UDP-glucuronate biosynthetic process; EXP:PseudoCAP.
DR   InterPro; IPR004104; Gfo/Idh/MocA-like_OxRdtase_C.
DR   InterPro; IPR000683; Gfo/Idh/MocA-like_OxRdtase_N.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF01408; GFO_IDH_MocA; 1.
DR   Pfam; PF02894; GFO_IDH_MocA_C; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell wall biogenesis/degradation;
KW   Lipopolysaccharide biosynthesis; NAD; Nucleotide-binding; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..316
FT                   /note="UDP-N-acetyl-2-amino-2-deoxy-D-glucuronate oxidase"
FT                   /id="PRO_0000419621"
FT   BINDING         11..13
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20690587"
FT   BINDING         32..37
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20690587"
FT   BINDING         55
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20690587"
FT   BINDING         81..84
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20690587"
FT   BINDING         101..102
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20690587"
FT   BINDING         130
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20690587"
FT   BINDING         171..172
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20690587"
FT   CONFLICT        213
FT                   /note="A -> T (in Ref. 1; AAC45853)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        238
FT                   /note="S -> W (in Ref. 2; AAM27797)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..7
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   TURN            8..10
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          11..13
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           14..23
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          27..32
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           39..43
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          49..53
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           54..64
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   TURN            68..70
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          74..77
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           81..83
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           84..93
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          97..100
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           108..121
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          125..127
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           130..133
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           135..146
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          153..161
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           166..169
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           175..178
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           181..197
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          199..208
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          210..219
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          222..229
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           232..234
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   TURN            237..242
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   STRAND          244..251
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           265..274
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   HELIX           281..296
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   TURN            304..306
FT                   /evidence="ECO:0007829|PDB:3OA2"
FT   TURN            309..311
FT                   /evidence="ECO:0007829|PDB:3OA2"
SQ   SEQUENCE   316 AA;  35718 MW;  838B976545FDF5E2 CRC64;
     MKNFALIGAA GYIAPRHMRA IKDTGNCLVS AYDINDSVGI IDSISPQSEF FTEFEFFLDH
     ASNLKRDSAT ALDYVSICSP NYLHYPHIAA GLRLGCDVIC EKPLVPTPEM LDQLAVIERE
     TDKRLYNILQ LRHHQAIIAL KDKVAREKSP HKYEVDLTYI TSRGNWYLKS WKGDPRKSFG
     VATNIGVHFY DMLHFIFGKL QRNVVHFTSE YKAAGYLEYE QARVRWFLSV DANDLPESVK
     GKKPTYRSIT VNGEEMEFSE GFTDLHTTSY EEILAGRGYG IDDARHCVET VNTIRSAVIV
     PASDNEGHPF VAALAR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024